Clinical Trial

Culturally Adapted Contingency Management

Name: Culturally Adapted Contingency Management — clinical trial record (NCT07443332)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2026-02-24; most recent amendment 2026-07-14.

Trial Details

NCT Number	NCT07443332
Lead Sponsor	Yale University Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Stimulant Use Disorders
Enrollment	70 participants
Start Date	2028-07
Primary Completion	2030-03 (estimated)
Study Completion	2030-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-16